---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000049"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-06-10T10:01:35+00:00"
generated_at: "2026-06-10T10:06:57.550316+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Elevance Health reaffirms FY2026 adjusted EPS at least $26.75, benefit expense ratio ~90.2%

## Summary
- Reaffirms FY2026 GAAP EPS guidance at least $19.85, including ~$6.90 net unfavorable items.
- Adjusted shareholders' earnings guidance unchanged at at least $26.75 per diluted share.
- Benefit expense ratio guidance reaffirmed at 90.2% ± 50 basis points.

## SEC filing metadata
- accession: 0001156039-26-000049
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-06-10T10:01:35+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000049/0001156039-26-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000049/elv-20260610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000049
- JSON: https://secwatch.observer/filing/0001156039-26-000049.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.